Insider Selling: NIOX Group (LON:NIOX) Insider Sells £13,236 in Stock

NIOX Group Plc (LON:NIOX) insider Garry Watts sold 16,545 shares of the business’s stock in a transaction that occurred on Tuesday, October 27th. The stock was sold at an average price of GBX 80, for a total value of £13,236.

NIOX Group Price Performance

NIOX opened at GBX 64 on Friday. The company’s 50 day simple moving average is GBX 67.09 and its 200-day simple moving average is GBX 63.06. NIOX Group Plc has a one year low of GBX 53.84 and a one year high of GBX 80. The company has a debt-to-equity ratio of 1.06, a current ratio of 4.60 and a quick ratio of 1.94. The stock has a market capitalization of £259.35 million, a P/E ratio of 39.26 and a beta of 0.92.

NIOX Group (LON:NIOX) last released its earnings results on Wednesday, September 30th. The company reported GBX 1.41 earnings per share (EPS) for the quarter. NIOX Group had a net margin of 14.74% and a return on equity of 10.01%. Sell-side analysts anticipate that NIOX Group Plc will post 1.17 earnings per share for the current fiscal year.

NIOX Group Company Profile

NIOX Group plc is a medical technology company focused on improving the lives of millions of people suffering from respiratory health issues globally. NIOX develops and markets innovative, non-invasive diagnostic products for chronic airway diseases, primarily asthma and COPD. Its lead product, NIOX VERO®, enables the accurate measurement of fractional exhaled nitric oxide (FeNO), an established biomarker for airway inflammation, supporting better diagnosis, monitoring and management of asthma and COPD in clinical and research settings.

Headquartered in the UK and listed on the London Stock Exchange (ticker: NIOX), the company operates internationally, serving healthcare professionals in over 50 countries.